Veeva Systems Inc
NYSE:VEEV
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
171.41
236.87
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Veeva Systems Inc
Veeva Systems Inc
Additional Paid In Capital
Veeva Systems Inc
Additional Paid In Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Additional Paid In Capital
$2.1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
26%
|
CAGR 10-Years
22%
|
|
|
Teladoc Health Inc
NYSE:TDOC
|
Additional Paid In Capital
$17.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Additional Paid In Capital
$1B
|
CAGR 3-Years
27%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Additional Paid In Capital
$823.9m
|
CAGR 3-Years
200%
|
CAGR 5-Years
138%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Additional Paid In Capital
$1.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Additional Paid In Capital
$2.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Veeva Systems Inc
Glance View
Veeva Systems Inc. is a cloud-based software company that specializes in providing innovative solutions for the life sciences industry. Founded in 2007, Veeva has grown into a leading player, helping pharmaceutical and biotechnology companies manage their critical data and workflow efficiently. With an array of products tailored to various functions such as clinical trials, regulatory compliance, and commercial operations, Veeva’s offerings are designed to streamline processes while ensuring compliance with the stringent regulations that govern the healthcare sector. The company has established a robust reputation and a vast customer base, including many of the world's most prominent drug manufacturers, which highlights its strategic importance in an ever-evolving industry. Investors looking at Veeva Systems should note the company’s impressive growth trajectory, characterized by consistent revenue increases and a strong margin profile. As healthcare increasingly shifts towards digital solutions, Veeva stands at the forefront of this transformation, capturing the growing demand for cloud-based applications. Moreover, Veeva’s commitment to innovation and its customer-centric approach position it well to capitalize on future opportunities within life sciences, particularly as the industry seeks to enhance efficiency and reduce costs. With a strong balance sheet and a business model that emphasizes recurring revenue through subscription services, Veeva Systems presents a compelling investment proposition for those interested in the intersection of technology and healthcare.
See Also
What is Veeva Systems Inc's Additional Paid In Capital?
Additional Paid In Capital
2.1B
USD
Based on the financial report for Jul 31, 2024, Veeva Systems Inc's Additional Paid In Capital amounts to 2.1B USD.
What is Veeva Systems Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
22%
Over the last year, the Additional Paid In Capital growth was 22%. The average annual Additional Paid In Capital growth rates for Veeva Systems Inc have been 24% over the past three years , 26% over the past five years , and 22% over the past ten years .
You don't have any saved screeners yet
